摘要
本文解读了《2024 ACC专家共识决策路径:射血分数降低心力衰竭治疗》的重点内容,着重分析了射血分数降低心力衰竭的“4大支柱”药物治疗方案。指南强调了早期和快速启动这些药物的重要性,以改善治疗效果、减少住院次数和降低死亡风险。
This article interprets the key points of the"2024 ACC Expert Consensus Decision Pathway:Treatment of Heart Failure with Reduced Ejection Fraction(HFrEF)".It focuses on the"four pillars"of pharmacotherapy for HFrEF,emphasizing the importance of early and rapid initiation of these medications to improve treatment outcomes,reduce hospitalizations,and decrease mortality risk.
作者
苑海涛
杨乐
YUAN Haitao;YANG Le(Department of Cardiology,Shandong Provincial Hospital,Jinan,250021,China)
出处
《临床心血管病杂志》
CAS
2024年第6期440-443,共4页
Journal of Clinical Cardiology
关键词
射血分数降低心力衰竭
解读
治疗
heart failure with reduced ejection fraction
interpretation
treatment
